| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/03/2011 | WO2011024028A1 Direct compression tablets of otilonium |
| 03/03/2011 | WO2011023734A1 Process for the precipitation of inhalable pharmaceutical agents in the propellant |
| 03/03/2011 | WO2011022861A1 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 03/03/2011 | WO2011003858A3 Pharmaceutical compositions and solid forms |
| 03/03/2011 | WO2011002425A3 Pharmaceutical composition increasing solubility and stability |
| 03/03/2011 | WO2011002423A3 Solubility enhancing pharmaceutical composition |
| 03/03/2011 | WO2011000835A3 Liposomes for pulmonary application |
| 03/03/2011 | WO2010144785A3 Diketopiperazine microparticles with defined isomer contents |
| 03/03/2011 | WO2010135131A3 Single-use, disposable strip for application of topical compositions |
| 03/03/2011 | WO2010129337A3 New oral formulations for tetrapyrrole derivatives |
| 03/03/2011 | WO2010128525A4 A formulation of ivabradine for treating the cardiovascular disease |
| 03/03/2011 | WO2010126168A3 Solid preparation |
| 03/03/2011 | WO2010125408A3 Prostata-norm rectal suppositories for the treatment of prostatitis |
| 03/03/2011 | WO2010123971A3 Hydrogels for combinatorial delivery of immune-modulating biomolecules |
| 03/03/2011 | WO2010121024A3 Silicone-peroxide compositions for long-term, controlled oxygen release |
| 03/03/2011 | WO2010120489A3 Drug delivery system and methods of use |
| 03/03/2011 | WO2010117957A3 Methods and materials for delivering molecules |
| 03/03/2011 | WO2010108077A3 Controlled release particulates containing water-insoluble drug |
| 03/03/2011 | WO2010102991A3 Riluzole liquid emulsions |
| 03/03/2011 | WO2010102923A3 Riluzole aqueous suspensions |
| 03/03/2011 | WO2010091362A3 Topical formulations comprising ion channel modulators |
| 03/03/2011 | WO2010085195A3 Coating composition and use thereof |
| 03/03/2011 | WO2008139264A3 Soft gel formulations |
| 03/03/2011 | WO2008129358A3 Oil producing microbes and methods of modification thereof |
| 03/03/2011 | WO2008053362A3 Bioresponsive polymers |
| 03/03/2011 | WO2008038155A3 Controlled-release pharmaceutical tablets |
| 03/03/2011 | US20110054442 Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease |
| 03/03/2011 | US20110054396 Balloon Catheter Devices With Drug-Coated Sheath |
| 03/03/2011 | US20110054375 Dressing comprising polyacrylate particles and use thereof |
| 03/03/2011 | US20110054347 Devices for Selective Recruitment, Isolation, Activation, and/or Elimination of Various Cell Populations |
| 03/03/2011 | US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets |
| 03/03/2011 | US20110054159 Rna interference mediating small rna molecules |
| 03/03/2011 | US20110054153 Method of purifying apo-2 ligand/trail usin crystallisation the cold |
| 03/03/2011 | US20110054152 Hydroxyalkyl Starch Derivatives |
| 03/03/2011 | US20110053981 Methods and Compositions Using Cholinesterase Inhibitors |
| 03/03/2011 | US20110053927 Nanoparticle formation via rapid precipitation |
| 03/03/2011 | US20110053903 Pharmaceutical compositions based on azetidine derivatives |
| 03/03/2011 | US20110053846 The use of gnrh antagonist peptide in the treatement of sex hormone-dependent diseases |
| 03/03/2011 | US20110053845 Localized vaginal delivery without detrimental blood levels |
| 03/03/2011 | US20110052717 Slow release pharmaceutical composition made of microparticles |
| 03/03/2011 | US20110052716 Adjuvant Comprising Aluminum, Oligonucleotide and Polycation |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052713 Repairing damaged nervous system tissue with nanoparticles |
| 03/03/2011 | US20110052712 Sprayable Polymers As Adhesion Barriers |
| 03/03/2011 | US20110052711 Controlled release multidrug formulations for spinal cord injury |
| 03/03/2011 | US20110052710 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052709 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052708 Methods and formulations for the delivery of pharmacologically active agents |
| 03/03/2011 | US20110052707 Combination of vitamin d and 25-hydroxyvitamin d 3 |
| 03/03/2011 | US20110052706 Pancreatine pellets and method of producing same |
| 03/03/2011 | US20110052705 Cartilage composition and process for producing the cartilage composition |
| 03/03/2011 | US20110052704 Tocotrienol compositions |
| 03/03/2011 | US20110052703 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 03/03/2011 | US20110052702 Method and Apparatus for Producing Organic Nanotubes |
| 03/03/2011 | US20110052701 Particulates of a crth2 antagonist |
| 03/03/2011 | US20110052700 Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride |
| 03/03/2011 | US20110052699 Drug delivery system with stabilising effect |
| 03/03/2011 | US20110052697 Aptamer-Directed Drug Delivery |
| 03/03/2011 | US20110052696 Dendrimers with interior and exterior functionalities comprising of azide or alkyne groups for post-functionalization by the huisgen click cycloaddition |
| 03/03/2011 | US20110052695 Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052693 Method for producing artificial skin |
| 03/03/2011 | US20110052692 Novel hydrogels and uses thereof |
| 03/03/2011 | US20110052691 Sustained Release Systems and Preparation Method Thereof |
| 03/03/2011 | US20110052690 Process for manufacture of a medicament with granulation and pan coating |
| 03/03/2011 | US20110052689 Sustained release of guaifenesin |
| 03/03/2011 | US20110052688 Solid dispersion composition |
| 03/03/2011 | US20110052687 Extended release pharmaceutical composition of paliperidone |
| 03/03/2011 | US20110052686 Modified release lamotrigine tablets |
| 03/03/2011 | US20110052685 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 03/03/2011 | US20110052684 Pharmaceutical composition |
| 03/03/2011 | US20110052683 Pharmaceutical preparation for treating cardiovascular disease |
| 03/03/2011 | US20110052682 Methods for enhancing the release and absorption of water insoluble active agents |
| 03/03/2011 | US20110052681 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 03/03/2011 | US20110052680 Encapsulation of oxidatively unstable compounds |
| 03/03/2011 | US20110052679 Solid naproxen concentrates and related dosage forms |
| 03/03/2011 | US20110052678 Method for treating age related macular degeneration |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052675 Orally Disintegrting Forms for Sustained Release and Controlled Release |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | US20110052673 Therapeutic compositions |
| 03/03/2011 | US20110052672 Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy |
| 03/03/2011 | US20110052671 Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes |
| 03/03/2011 | US20110052670 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 03/03/2011 | US20110052669 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 03/03/2011 | US20110052668 Identification and Characterization of a Specific CCK-C Receptor Antibody for Human Pancreatic Cancer and Its Use for Early Detection and Staging of Pancreatic Cancer |
| 03/03/2011 | US20110052667 Compositions and methods for inhibiting angiogenesis and tumorigenesis |
| 03/03/2011 | US20110052666 Compositions, Methods, and Systems for SIRNA Delivery |
| 03/03/2011 | US20110052665 Haemostatic material |
| 03/03/2011 | US20110052664 Antimicrobial Medical Dressings and Protecting Wounds and Catheter Sites |
| 03/03/2011 | US20110052663 Hemostatic Sponge with Enzyme and Method of Manufacture |
| 03/03/2011 | US20110052661 Pet dental hygiene product |
| 03/03/2011 | US20110052660 Ceramic scaffolds for bone repair |
| 03/03/2011 | US20110052659 Implants for administering substances and methods of producing implants |
| 03/03/2011 | US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 03/03/2011 | US20110052657 Implants for administering substances and methods of producing implants |
| 03/03/2011 | US20110052652 Solid pharmaceutical composition comprising agglomerated nanoparticles and a process for producing the same |
| 03/03/2011 | US20110052650 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest |
| 03/03/2011 | US20110052648 Oral modified-release formulations containing thiazepines |